Skip to content

Clinical trials

Phase 2 Diabetic Neuropathies trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetic Neuropathies Phase: Phase 2 Country / region: Germany Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20073
20091
20112
20122
20131
20181
20211
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Terminated2
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Tris Pharma, Inc.3
AbbVie (prior sponsor, Abbott)2
Glenmark Pharmaceuticals Ltd. India2
Bayer1
Hoffmann-La Roche1
Martin-Luther-Universität Halle-Wittenberg1
Novartis Pharmaceuticals1
Swedish Orphan Biovitrum1
Syqe Medical1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetic Neuropathies13
Neuralgia5
Diabetes Mellitus4
Pain3
Chronic Pain2
Agnosia1
Marijuana Abuse1
Mononeuropathies1
Respiratory Aspiration1

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.